2017
DOI: 10.1590/s2175-97902017000300178
|View full text |Cite
|
Sign up to set email alerts
|

Cost-effectiveness of insulin analogs from the perspective of the Brazilian public health system

Abstract: Human insulin is provided by the Brazilian Public Health System (BPHS) for the treatment of diabetes, however, legal proceedings to acquire insulin analogs have burdened the BPHS health system. The aim of this study was to perform a cost-effectiveness analysis to compare insulin analogs and human insulins. This is a pharmacoeconomic study of cost-effectiveness. The direct medical cost related to insulin extracted from the Ministry of Health drug price list was considered. The clinical results, i.e. reduction i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 15 publications
0
2
0
Order By: Relevance
“…Our hospital is a public hospital that is part of the Brazilian national unified public health system ( Sistema Único de Saúde – SUS) ( 17 ), in which human insulins (NPH and regular) are the standard treatment defined by the Brazilian Ministry of Health ( 30 ). Pharmacoeconomic studies that evaluated human insulins and insulin analogues have suggested that the use of human insulins are the best options in relation to the cost of treatment ( 31 , 32 ). However, the majority of inpatient insulin therapy studies have been performed with insulin analogues.…”
Section: Discussionmentioning
confidence: 99%
“…Our hospital is a public hospital that is part of the Brazilian national unified public health system ( Sistema Único de Saúde – SUS) ( 17 ), in which human insulins (NPH and regular) are the standard treatment defined by the Brazilian Ministry of Health ( 30 ). Pharmacoeconomic studies that evaluated human insulins and insulin analogues have suggested that the use of human insulins are the best options in relation to the cost of treatment ( 31 , 32 ). However, the majority of inpatient insulin therapy studies have been performed with insulin analogues.…”
Section: Discussionmentioning
confidence: 99%
“…Users of analogue insulin via pen devices showed better adherence, and this type of insulin was more cost-effective. A pharmacoeconomic study conducted in Brazil in 2017 ( 21 ) concluded that human insulins were the best treatment option for diabetes mellitus based on direct cost analysis.…”
Section: Introductionmentioning
confidence: 99%